All in Technology
With billions of dollars now directed toward its development, radioligand therapy has the potential to transform cancer treatment. The excitement is driving cancer centers nationwide to expand theranostic trials which pair RLT with novel radiopharmaceutical PET or SPECT imaging. However, one critical challenge looms: a shortage of nuclear medicine and radiology physician experts, technologists, and nursing staff capable of delivering this therapy at scale.
“Short of a silver bullet cure for metastatic breast cancer, can we achieve close to 100% reduction in breast cancer mortality using current screening technologies? A careful re-assessment and re-implementation of current screening approaches may get us much closer. If this topic interests you, read on.”
“Pathfinder is a tool to bridge diagnostic radiology to clinical outcomes by linking radiology with pathology…While I still have a bloated follow-up folder in PACS that I haven’t gotten around to look at from before Pathfinder, I am caught up on everything after Pathfinder became available because Pathfinder’s Match function makes follow-up effortless.”
